Harbert Fund Advisors’s Tenet Healthcare THC Stock Holding History

Harbert Fund Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$166K	–	131
2024 Q3	$166K	Buy	+1,000	New	+$151K	0.1%	105

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Harbert Fund Advisors's THC Position: Q2 2025 in Review

Harbert Fund Advisors sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 7,500 shares — an estimated $1.01M sold.

Harbert Fund Advisors first reported a position in THC in Q1 2024 and held it in 4 quarters. The position peaked at $1.01M in Q1 2025. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

Harbert Fund Advisors reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
Harbert Fund Advisors sold 7,500 Tenet Healthcare shares in Q2 2025, an estimated $1.01M.
Harbert Fund Advisors first reported a position in Tenet Healthcare in Q1 2024 and held it in 4 quarters.
Harbert Fund Advisors's Tenet Healthcare position peaked at $1.01M in Q1 2025.
626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Harbert Fund Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.